Consequently, 315 pathogenic BRCA variants were identified, and an odds ratio of greater than 4.0 were found for biliary tract cancer in BRCA1, esophageal cancer in BRCA2, and gastric cancer in BRCA1 and BRCA23. This evidence concerns the gene BRCA1 and biliary tract cancer.